Back to Authors

Pinto, A. A.

A5104127000 | I4210141868

Mayo Clinic

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Citations 1

Phase 1 trial of EO2463 peptide‐based immunotherapy as monotherapy and in combination with lenalidomide and rituximab in indolent non‐Hodgkin lymphoma; EONHL1‐20/SIDNEY

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 581-582

10.1002/hon.3164_435